GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea

Go back to GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea
AGENUS (NASDAQ: AGEN) Delayed: 8.26 +0.41 (5.22%)
Previous Close $7.85    52 Week High $7.49 
Open $7.80    52 Week Low $2.61 
Day High $8.33    P/E N/A 
Day Low $7.60    EPS $-1.10 
Volume 439,371       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 51.16 +0.94 (1.87%)
Previous Close $50.22    52 Week High $45.58 
Open $50.75    52 Week Low $37.82 
Day High $51.19    P/E N/A 
Day Low $50.46    EPS $0.00 
Volume 1,128,343